Fatal outcomes in family transmission of mycoplasma pneumoniae

Clinical Infectious Diseases

Volumn 54, Issue 2, 2012, Pages 225-231

  Kannan, T R ^a   Hardy, R D ^b,e   Coalson, J J ^c   Cavuoti, D C ^d   Siegel, J D ^b   Cagle, M ^a   Musatovova, O ^a   Herrera, C ^a   Baseman, J B ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d Department of Pathology ^*  (United States)

^e D Specialists PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; COMMUNITY ACQUIRED RESPIRATORY DISTRESS SYNDROME TOXIN; UNCLASSIFIED DRUG;

ADOLESCENT; AIRWAY; ARTICLE; AUTOPSY; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BLOOD SAMPLING; BRAIN EDEMA; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; EXUDATE; FAMILY; FATALITY; FEMALE; HOUSEHOLD; HUMAN; HUMAN TISSUE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFECTION CONTROL; LUNG EDEMA; LUNG PARENCHYMA; LYMPHOPLASMACYTIC BRONCHIOLITIS; MALE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PARENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY ARREST; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SIBLING;

ADOLESCENT; CHILD; FAMILY; FATAL OUTCOME; FEMALE; HUMANS; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; QUARANTINE; RETROSPECTIVE STUDIES; TEXAS;

EID: 84555204792     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir769     Document Type: Article

References (30)

1. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008; 32:956-73.
2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 17:697-728. (Pubitemid 39372513)
3. Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci USA 2006; 103:6724-9.
4. Techasaensiri C, Tagliabue C, Cagle M, et al. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among Mycoplasma pneumoniae strains. Am J Respir Crit Care Med 2010; 182:797-804.
5. Kannan TR, Musatovova O, Balasubramanian S, et al. Mycoplasma pneumoniae community acquired respiratory distress syndrome toxin expression reveals growth phase and infection-dependent regulation. Mol Microbiol 2010; 76:1127-41.
6. Kannan TR, Provenzano D, Wright JR, Baseman JB. Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect Immun 2005; 73:2828-34. (Pubitemid 40570350)
7. Rollins S, Colby T, Clayton F. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch Pathol Lab Med 1986; 110:34-41. (Pubitemid 16011808)
8. Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West J Med 1995; 162:133-42.
9. Llibre JM, Urban A, Garcia E, Carrasco MA, Murcia C. Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection. Clin Infect Dis 1997; 25:1340-2. (Pubitemid 28022667)
10. Fischman RA, Marschall KE, Kislak JW, Greenbaum DM. Adult respiratory distress syndrome caused by Mycoplasma pneumoniae. Chest 1978; 74:471-3. (Pubitemid 9047810)
11. Simmons BP, Aber RC. Mycoplasma pneumoniae pneumonia: symptoms mimicking pulmonary embolism with infarction. JAMA 1979; 241:1268-9. (Pubitemid 9222058)
12. Tablan OC, Reyes MP. Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia. Am J Med 1985; 79:268-70. (Pubitemid 15246260)
13. Leonardi S, del Giudice MM, Spicuzza L, Saporito M, Nipitella G, La Rosa M. Lung abscess in a child with Mycoplasma pneumoniae infection. Eur J Pediatr 2010; 169:1413-5.
14. Berg CP, Kannan TR, Klein R, et al. Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis. Liver Int 2009; 29:797-809.
15. Ursi D, Dirven K, Loens K, Ieven M, Goossens H. Detection of Mycoplasma pneumoniae in respiratory samples by real-time PCR using an inhibition control. J Microbiol Methods 2003; 55:149-53. (Pubitemid 37297654)
16. Sasaki T, Kenri T,Okazaki N, et al. Epidemiological study ofMycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene. J Clin Microbiol 1996; 34:447-9. (Pubitemid 26035132)
17. Kannan TR, Coalson JJ, Cagle M, Musatovova O, Hardy RD, Baseman JB. Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model. J Infect Dis 2011; 204:1596-1604.
18. Kenny GE, Newton RM. Close serological relationship between glycolipids of Mycoplasma pneumoniae and glycolipids of spinach. Ann New York Acad Sci 1973; 225:54-61.
19. Biberfeld G. Antibodies to brain and other tissues in cases ofMycoplasma pneumoniae infection. Clin Exp Immunol 1971; 8:319-33.
20. Maisel JC, Babbitt LH, John TJ. Fatal Mycoplasma pneumoniae infection with isolation of organisms from lung. JAMA 1967; 202:287-90.
21. Koletsky RJ, Weinstein AJ. Fulminant Mycoplasma pneumoniae infection: report of a fatal case, and a review of the literature. Am Rev Respir Dis 1980; 122:491-6.
22. Williamson J, Marmion BP, Kok T, Antic R, Harris RJ. Confirmation of fatal Mycoplasma pneumoniae infection by polymerase chain reaction detection of the adhesin gene in fixed lung tissue. J Infect Dis 1994; 170:1052-3. (Pubitemid 24296603)
23. Carrascosa MF, Lucena MI, Andrade RJ, et al. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther 2009; 31:1014-9.
24. Wachowski O, Demirakca S, Muller KM, Scheurlen W. Mycoplasma pneumoniae associated organising pneumonia in a 10 year old boy. Arch Dis Child 2003; 88:270-2. (Pubitemid 36269520)
25. Cimolai N, Taylor GP, Mah D, Morrison BJ. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol Immunol 1992; 36:465-78.
26. Hardy RD, Coalson JJ, Peters J, et al. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS One 2009; 4:e7562.
27. Degrange S, Cazanave C, Charron A, Renaudin H, Bebear C, Bebear CM. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol 2009; 47:914-23.
28. Loens K, Ursi D, Goossens H, Ieven M. Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J Clin Microbiol 2003; 41:4915-23. (Pubitemid 37429897)
29. Muir MT, Cohn SM, Louden C, Kannan TR, Baseman JB. Novel toxin assays implicate Mycoplasma pneumoniae in prolonged ventilator course and hypoxemia. Chest 2011; 139:305-10.
30. Peters J, Singh H, Brooks EG, et al. Persistence of community-acquired respiratory distress syndrome toxin-producing mycoplasma pneumoniae in refractory asthma. Chest 2011; 140:401-7.